Billionaires Are Buying These High-Yield Dividend Stocks Left and Right. Should You Follow Their Lead?
Billionaires Flock to Dividend Stocks: Should You?
Recent SEC disclosures reveal that high-yield dividend healthcare stocks are popular among billionaire fund managers. Pfizer, with a 5.8% dividend yield, has seen significant purchases by investors like John Overdeck and David Siegel, despite recent declines due to reduced COVID-19 related sales. The company's promising financial outlook and ongoing acquisitions suggest potential for long-term gains.
Conversely, Walgreens Boots Alliance, despite its 5.5% yield, faces challenges in a low-growth retail pharmacy sector and has made questionable strategic decisions, such as heavy investment in VillageMD followed by clinic closures. Despite billionaire interest, the company's future remains uncertain, making it a less attractive option for potential investors.